These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6676670)

  • 1. [Experimental study on immunological effect of splenectomy on tumor-bearers].
    Tanemura H; Saji S; Takekoshi T; Yamamoto S; Oshita H; Sakata K
    Nihon Geka Gakkai Zasshi; 1983 Sep; 84(9):982-6. PubMed ID: 6676670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunological effect of splenectomy in tumor-bearing rat].
    Saji S; Sugiyama Y; Miya K; Oshita H; Yokoyama Y; Yamamoto S; Takekoshi T; Sakata K
    Nihon Geka Gakkai Zasshi; 1983 Mar; 84(3):179-85. PubMed ID: 6674791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in immunological function of spleen in rats implanted with N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric cancer].
    Matsumoto K
    Nihon Geka Gakkai Zasshi; 1994 Jul; 95(7):448-57. PubMed ID: 8072484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunological evaluation of splenectomy in tumor-bearing mice].
    Yamagishi H; Naito K; Maeda Y; Kurioka H; Kobayashi M; Fujimori C; Iguchi K; Tanaka T; Hashimoto I
    Nihon Geka Gakkai Zasshi; 1983 Sep; 84(9):987-91. PubMed ID: 6676671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental study on levamisole modulation of antitumor immunity--1].
    Saji S; Ooshita H; Adachi Y; Yamamoto S; Takekoshi T; Sakata K
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1418-26. PubMed ID: 6985198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental study on merits and demerits of splenectomy in tumor bearers.
    Saji S; Oshita H; Yamamoto S; Takekoshi T; Sakata K
    J Surg Oncol; 1983 May; 23(1):35-40. PubMed ID: 6601744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vivo antitumor effect of LAK cells induced from various lymphocytes--experimental study in rats].
    Goshima H; Saji S; Tanemura H; Takao H; Tachibana S; Oiwa T; Keshikawa I
    Nihon Geka Gakkai Zasshi; 1989 Jul; 90(7):972-9. PubMed ID: 2796984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
    Fuyama S; Yamamoto H; Fujii Y; Arai S
    Cancer Res; 1986 Nov; 46(11):5548-52. PubMed ID: 2428480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of two distinct subpopulations of suppressor cells in rats bearing chemically induced tumors.
    Iguchi S; Ishii Y; Yamaoka H; Sato N; Kikuchi K
    Neoplasma; 1981; 28(1):51-8. PubMed ID: 6456424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphokine-activated killer cells in rats: analysis of tissue and strain distribution, ontogeny, and target specificity.
    Vujanovic NL; Herberman RB; Hiserodt JC
    Cancer Res; 1988 Feb; 48(4):878-83. PubMed ID: 3257411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming suppression of antitumor immune reactivity in tumor-bearing rats by treatment with bleomycin.
    Xu ZY; Hosokawa M; Morikawa K; Hatakeyama M; Kobayashi H
    Cancer Res; 1988 Dec; 48(23):6658-63. PubMed ID: 2460226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of spleen on immune function of rats with liver cancer complicated by liver cirrhosis.
    Yao YM; Liu QG; Yang W; Zhang M; Ma QY; Pan CE
    Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):242-6. PubMed ID: 14599977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NK cells from mammary tumor bearing mice do not exert natural killer activity but function as antibody dependent cellular cytotoxicity effectors.
    Rivera LM; Lopez DM
    Anticancer Res; 1993; 13(1):177-84. PubMed ID: 8476211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early appearance and activation of natural killer cells in tumor-infiltrating lymphoid cells during tumor development.
    Kurosawa S; Matsuzaki G; Harada M; Ando T; Nomoto K
    Eur J Immunol; 1993 May; 23(5):1029-33. PubMed ID: 8477798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes of natural killer activity following local 60Co irradiation in intracranial tumor-bearing mice (author's transl)].
    Otsuka S; Suda K; Yamashita J; Takeuchi J; Handa H
    No To Shinkei; 1982 Apr; 34(4):393-8. PubMed ID: 7093076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immune status of the spleen and surgical treatment in patients with advanced gastric cancer].
    Zhu Z
    Zhonghua Yi Xue Za Zhi; 1992 Jun; 72(6):330-3, 381. PubMed ID: 1332809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of the spleen in OK-432 immunotherapy and characterization of effector cells].
    Yamagishi H; Naito K; Maeda Y; Kobayashi M; Kurioka H; Fujimori C; Tanaka T; Hashimoto I
    Gan To Kagaku Ryoho; 1983 Jul; 10(7):1670-8. PubMed ID: 6870309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunological response of regional lymph nodes after cryosurgery in rats].
    Miya K; Saji S; Morita T; Niwa H; Takao H; Kida H; Sakata K
    Nihon Geka Gakkai Zasshi; 1986 Mar; 87(3):273-7. PubMed ID: 3713680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melphalan-induced enhancement of antitumor immune reactivity in thymocytes of adult BALB/c mice bearing a large MOPC-315 tumor.
    Bartik MM; Takesue BY; Mokyr MB
    Cancer Res; 1987 Sep; 47(18):4848-55. PubMed ID: 3497711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of splenectomy on the immune response of BALB/c mice bearing an immunoglobulin M plasmacytoma (TEPC-183).
    Havas HF; Berney S; Goodis A; Schiffman G
    Cancer Res; 1979 Sep; 39(9):3783-7. PubMed ID: 476702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.